Upgrade to SI Premium - Free Trial

Phio Pharmaceuticals Corp. (PHIO)

1.06 -0.08 (7.02%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/14/26 *Est.)

Latest Headlines

Phio Pharmaceuticals Announces Participation in Live Virtual Non-Deal Roadshow Series May 26, 2026 7:10 AM - StreetInsider Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series May 26, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026 May 12, 2026 7:01 AM - StreetInsider Phio Pharmaceuticals Corp. (PHIO) Misses Q1 EPS by 34c May 7, 2026 6:27 PM - StreetInsider Form 10-Q Phio Pharmaceuticals For: Mar 31 May 7, 2026 4:29 PM - SEC Filing Form 8-K Phio Pharmaceuticals For: May 07 May 7, 2026 4:19 PM - SEC Filing Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update May 7, 2026 4:07 PM - StreetInsider Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series April 23, 2026 7:01 AM - StreetInsider Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026 April 13, 2026 7:01 AM - StreetInsider Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026 April 9, 2026 7:03 AM - StreetInsider Form 8-K Phio Pharmaceuticals For: Apr 08 April 8, 2026 4:16 PM - SEC Filing Form 424B5 Phio Pharmaceuticals April 8, 2026 4:13 PM - SEC Filing Phio Pharmaceuticals signs manufacturing agreement for cancer drug March 30, 2026 7:18 AM - StreetInsider Form 8-K Phio Pharmaceuticals For: Mar 30 March 30, 2026 7:16 AM - SEC Filing Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 March 30, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals to present PH-762 cancer study results at dermatology meeting March 23, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancemen March 23, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office March 16, 2026 11:32 AM - StreetInsider Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing March 13, 2026 8:35 AM - StreetInsider Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th March 10, 2026 10:21 AM - Globe NewsWire Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT March 10, 2026 7:59 AM - Globe NewsWire Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT March 10, 2026 7:02 AM - StreetInsider Full Article List